IFNG and acute myeloid leukemia: As shown in Figure 3b, the number of IFN-γ+ cells in not depleted control samples was 2.4-fold lower in AML compared to HV (0.5 ± 0.2 and 1.2 ± 0.6% respectively; P = 0.025).